GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Marketable Securities

Meribank Biotech Co (ROCO:4724) Marketable Securities : NT$0.0 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Meribank Biotech Co's Marketable Securities for the quarter that ended in Dec. 2023 was NT$0.0 Mil.

Meribank Biotech Co's annual Marketable Securities increased from Dec. 2021 (NT$94.1 Mil) to Dec. 2022 (NT$122.7 Mil) but then declined from Dec. 2022 (NT$122.7 Mil) to Dec. 2023 (NT$0.0 Mil).


Meribank Biotech Co Marketable Securities Historical Data

The historical data trend for Meribank Biotech Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Marketable Securities Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial 104.60 45.90 94.10 122.70 -

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.10 113.70 122.70 108.00 -

Meribank Biotech Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Meribank Biotech Co  (ROCO:4724) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Meribank Biotech Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Meribank Biotech Co (ROCO:4724) Business Description

Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines